| abstract |
Provided are diagnostic and therapeutic methods and compositions useful in the management of various cancers expressing 24P4C12, particularly prostate cancer. A polynucleotide comprising a plurality of specific sequences, a polynucleotide having a sequence represented by a specific sequence from nucleotide residue number 6 to nucleotide residue number 2138, or a polynucleotide encoding a 24P4C12 polypeptide. The polypeptide sequence consists of a polynucleotide encoded by a cDNA contained in a plasmid called p24P4C12-GTE5 or p24P4C12-GTE9 deposited with the American Type Culture Collection under accession numbers 207129 and 207084, respectively. [Selection figure] None |